Evidence map›Paper›PMID 31294331›Full record

ArticleResearch and practice in thrombosis and haemostasis2019

Successful management of refractory bleeding in liver failure with tranexamic acid: Case report and literature review.

Saranya Kodali, Chris E Holmes, Eswar Tipirneni, Christina R Cahill, Andrew J Goodwin, Mary Cushman

Open access · goldAbstract readCase Reports
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Saranya KodaliDivision of Hematology Oncology, Department of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont.
Chris E HolmesDivision of Hematology Oncology, Department of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont.
Eswar TipirneniDivision of Hematology Oncology, Department of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont.
Christina R CahillLarner College of Medicine at the University of Vermont Burlington Vermont.
Andrew J GoodwinDepartment of Pathology & Laboratory Medicine Larner College of Medicine at the University of Vermont Burlington Vermont.
Mary CushmanDivision of Hematology Oncology, Department of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont.ORCID https://orcid.org/0000-0002-7871-6143
University of Vermont · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 50-year-old woman with advanced cirrhosis presented with spontaneous subdural hematoma. She had a worsening clinical course following craniotomy despite administration of multiple blood products. With elevation in D-dimer, persistently low fibrinogen and poor response to factor/fibrinogen replacement therapies, we had a suspicion for uncontrolled fibrinolysis. A literature review was conducted on treatment of hyperfibrinolysis in cirrhosis, finding 4 reports in which antifibrinolytics were used to control bleeding with different outcomes. The dose of tranexamic acid used in our patient was employed from previous experience in trauma patients. We transitioned from intravenous to oral administration based on expected pharmacokinetics. Our patient had a successful outcome with resolution of bleeding.

Indexed as

D‐dimerfibrinolysisliver cirrhosisspontaneous subdural hematomatranexamic acid

Identifiers

PMID31294331
PMCPMC6611358
OpenAlexW2941739908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.